Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/03/2014 | EP2772270A1 Emulsified hydrogel composition and a production method therefor |
09/03/2014 | EP2772257A1 Formulations of quinolinones |
09/03/2014 | EP2772252A1 Oxybutynin-containing transdermal absorption preparation |
09/03/2014 | EP2772251A1 Protamine/RNA nanoparticles for immunostimulation |
09/03/2014 | EP2772250A1 Enteric composition for the manufacture of soft capsule wall |
09/03/2014 | EP2772249A1 Method and composition for treating ocular hypertension and glaucoma |
09/03/2014 | EP2772248A1 Pharmaceutical composition and kit for treating bacterial infections |
09/03/2014 | EP2772247A1 Surface-modified ultraviolet blocking powder and ultraviolet blocking composition including same |
09/03/2014 | EP2772225A1 Ocular therapeutic agent delivery devices and methods for making and using such devices |
09/03/2014 | EP2771033A1 Protein formulations containing amino acids |
09/03/2014 | EP2771023A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d |
09/03/2014 | EP2771013A1 Topical pharmaceutical compositions comprising acyclovir |
09/03/2014 | EP2770987A1 Novel compounds that are erk inhibitors |
09/03/2014 | EP2770986A1 Apparatus and method for producing controlled dosage of bioactive agent |
09/03/2014 | EP2770985A1 Artemisinin and berberine compositions and methods of making |
09/03/2014 | EP2770984A1 Device and method for sustained release of therapeutic agent |
09/03/2014 | EP2770983A1 Implantable drug delivery compositions and methods of treatment thereof |
09/03/2014 | EP2770982A1 Implantable rasagiline compositions and methods of treatment thereof |
09/03/2014 | EP2770981A1 Implantable tizanidine compositions and methods of treatment thereof |
09/03/2014 | EP2770980A1 Limit size lipid nanoparticles and related methods |
09/03/2014 | EP2770979A1 Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus |
09/03/2014 | EP2770978A1 Anti-flush compositions |
09/03/2014 | EP2770977A1 Novel dosage form |
09/02/2014 | US8822675 Low-substituted hydroxypropylcellulose and solid preparation comprising the same |
09/02/2014 | US8822549 Buffered oxygen therapeutic |
09/02/2014 | US8822546 Flowable pharmaceutical depot |
09/02/2014 | US8822493 SNS-595 and methods of using the same |
09/02/2014 | US8822492 Use of huperzine for disorders |
09/02/2014 | US8822489 Abuse deterrent compositions and methods of making same |
09/02/2014 | US8822477 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis |
09/02/2014 | US8822436 Compositions for oral administration of zoledronic acid or related compounds for treating disease |
09/02/2014 | US8822429 Citicoline for the treatment of glaucoma and ocular hypertension |
09/02/2014 | US8822428 Double-stranded RNA oligonucleotides which inhibit tyrosinase expression |
09/02/2014 | US8822423 Affinity peptides toward infliximab |
09/02/2014 | US8822410 Tympanic membrane permeating ear drops and uses thereof |
09/02/2014 | US8822219 Method for preparing biological tissues for use in biological prostheses |
09/02/2014 | US8822156 Methods for rapid identification of pathogens in humans and animals |
09/02/2014 | US8821958 Method for electrostatic coating of a stent |
09/02/2014 | US8821946 Calcium carbonate granulation |
09/02/2014 | US8821944 Polymorph compositions, methods of making, and uses thereof |
09/02/2014 | US8821943 Methods and compositions for targeted delivery of therapeutic agents |
09/02/2014 | US8821942 Highly compressible, low density ground calcium carbonate granulation and a related method of preparation |
09/02/2014 | US8821941 Hair removal with nanoparticles |
09/02/2014 | US8821940 Thermal treatment of the skin surface with nanoparticles |
09/02/2014 | US8821939 Bioactive agent delivery particles |
09/02/2014 | US8821938 Porous drug matrices and methods of manufacture thereof |
09/02/2014 | US8821937 Methods of treating cardiovascular disorders associated with atherosclerosis |
09/02/2014 | US8821936 Solid pharmaceutical formulation |
09/02/2014 | US8821935 Microcapsules with modified release of active principles with low solubility for oral delivery |
09/02/2014 | US8821934 Pullulan-containing powder, process for producing the same and use thereof |
09/02/2014 | US8821933 Polymers and hydrogels |
09/02/2014 | US8821932 Pharmaceutical compositions |
09/02/2014 | US8821931 Micro-particles containing a 3-D polymeric structure |
09/02/2014 | US8821930 Modified release preparations containing oxcarbazepine and derivatives thereof |
09/02/2014 | US8821929 Tamper resistant dosage forms |
09/02/2014 | US8821928 Controlled release pharmaceutical compositions for prolonged effect |
09/02/2014 | US8821927 Pharmaceutical composition |
09/02/2014 | US8821926 Tablet containing hardly soluble active ingredient |
09/02/2014 | US8821925 Ubiquinol and alpha lipoic acid compositions |
09/02/2014 | US8821924 Rhein or diacerein compositions |
09/02/2014 | US8821923 Using bucky paper as a therapeutic aid in medical applications |
09/02/2014 | US8821922 Compositions and methods for polymer-caged liposomes |
09/02/2014 | US8821921 Vitamin D3 for the transdermal treatment of pain and inflammation |
09/02/2014 | US8821920 Therapeutic patch for transdermal delivery of capsaicin |
09/02/2014 | US8821919 Wound debridement |
09/02/2014 | US8821918 Cross-linked gelatin composition comprising a wetting agent |
09/02/2014 | US8821916 Medical dressing comprising an antimicrobial silver compound |
09/02/2014 | US8821914 Non-abusable pharmaceutical composition comprising opioids |
09/02/2014 | US8821913 Controlled releases system containing temozolomide |
09/02/2014 | US8821906 Biocompatible polymer |
09/02/2014 | US8821904 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies |
09/02/2014 | US8821900 Anti-adhesion material |
09/02/2014 | US8821899 Method and process for the production of multi-coated recognitive and releasing systems |
09/02/2014 | US8821898 Active compound combinations having insecticidal and acaricidal properties |
09/02/2014 | US8821870 Method for treating atrophic age related macular degeneration |
09/02/2014 | US8821859 Methods and articles for the delivery of therapeutic agents |
09/02/2014 | US8821853 Anti-fatty liver agent |
09/02/2014 | US8821849 Internal clamp for surgical procedures |
09/02/2014 | US8821521 Gastro-intestinal device and method for treating addiction |
09/02/2014 | US8821479 Medical device with an energy supply having at least two energy sources |
09/02/2014 | US8821473 Methods and compositions to treat myocardial conditions |
09/02/2014 | US8821457 Punctal plug containing drug formulation |
09/02/2014 | US8821456 Daneshvar medication pads, suppositories and methods |
09/02/2014 | US8821437 Pharmaceutical device for the administration of substances to patients |
09/02/2014 | US8820323 Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
09/02/2014 | CA2776702C Topical dapsone for the treatment of acne |
09/02/2014 | CA2693644C Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof |
09/02/2014 | CA2642952C Pharmaceutical composition comprising oseltamivir phosphate |
09/02/2014 | CA2619744C Formulation having accurate dose-dividing function |
08/28/2014 | WO2014130998A1 Surface functionalized porous silicon |
08/28/2014 | WO2014130994A1 Nanoparticles for controlled release of anti-biofilm agents |
08/28/2014 | WO2014130921A1 Particle formulations for delivery of tlr agonists and antigens |
08/28/2014 | WO2014130866A2 Targeted buccal delivery of agents |
08/28/2014 | WO2014130846A1 Transdermal drug delivery using amphiphilic dendron-coil micelles |
08/28/2014 | WO2014130811A1 Interferon beta formulation |
08/28/2014 | WO2014130759A1 Methods of using histamine receptor agonists and antagonists |
08/28/2014 | WO2014130638A1 Combinations of indigo naturalis and berberine and uses thereof |
08/28/2014 | WO2014130488A1 Functionalized nanoparticles for medical treatments |
08/28/2014 | WO2014130432A1 Methods and compositions for improving appearance and formation of scar tissue |
08/28/2014 | WO2014130429A2 Caged platinum nanoclusters for anticancer chemotherapeutics |